Biologic Drugs

Sep 01, 2018
Pharmaceutical Technology
Immobilizing the antibodies on a solid-phase support, such as a resin, and carrying out the conjugation of the payload-linker while the antibodies are bound to that support will prevent aggregation at its source.
Aug 14, 2018
By Pharmaceutical Technology Editors
Drug product approval from FDA follows previous approvals from European and Japanese authorities.
Aug 13, 2018
By Pharmaceutical Technology Editors
The new drug, Onpattro (patisiran), by Alnylam Pharmaceuticals, is in a new class of drugs called small interfering ribonucleic acid (siRNA) treatment.
Aug 06, 2018
By Pharmaceutical Technology Editors
The companies will collaborate on the discovery, development, and commercialization of cell therapies for cancer.
Aug 02, 2018
Pharmaceutical Technology
Development costs and time to market continue to put pressure on the biopharma industry, driving the need for innovation in methods and technologies.
Aug 02, 2018
Pharmaceutical Technology
Frustrated by slow market adoption, Gottlieb maps out new plan for biosimilar competition.
Aug 02, 2018
Pharmaceutical Technology
Materials in contact with a drug must be fully characterized to ensure they do not negatively affect the safety and efficacy of the product.
Aug 01, 2018
Pharmaceutical Technology
CMOs have been active over the past year in expanding their biologics production and capabilities.
Jul 19, 2018
In launching FDA’s Biosimilar Action Plan, Gottlieb takes innovator companies to task for delaying competitive biosimilar products.
Jul 19, 2018
By Pharmaceutical Technology Editors
The company has run into a snag in producing Kymriah for the diffuse large B-cell lymphoma patient population, the second indication for which the therapy was recently approved by FDA.
native1_300x100
lorem ipsum